| Title: | Contributions of Common, Rare, and Somatic Genetic Variants to Incidence of Atrial Fibrillation |
| Journal: | JAMA Cardiology |
| Published: | 1 Dec 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41060636/ |
| DOI: | https://doi.org/10.1001/jamacardio.2025.3664 |
| URL: | https://pmc.ncbi.nlm.nih.gov/articles/PMC12509083/ |
Publication 17279
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Importance: Atrial fibrillation (AF) has a complex genetic architecture involving common, rare, and somatic variants. The association between these components requires further investigation.</p>
Objective: To examine the individual and combined contributions of polygenic, monogenic, and somatic genetic variants to AF incidence, and develop an integrated genomic model (IGM-AF) for improved risk prediction.</p>
Design, Setting, and Participants: This cohort study used whole-genome sequence data from participants of the UK Biobank, with follow-up for AF events through hospital records, death registries, and self-report. The UK Biobank recruited participants aged 40 to 69 years in the UK between 2006 and 2010. Study data were analyzed from August 2022 to November 2024.</p>
Exposures: IGM-AF comprising an AF polygenic risk score (PRS), a composite rare variant gene set (AFgeneset), and somatic variants associated with clonal hematopoiesis of indeterminate potential (CHIP). Clinical AF risk was estimated using the Cohorts for Heart and Aging Research in Genomic Epidemiology AF (CHARGE-AF) score.</p>
Main Outcomes and Measures: The primary outcome was hazard ratios (HRs) for 5-year incident AF attributable to PRS, AFgeneset, CHIP, and their interactions. The predictive performance of IGM-AF and its components was quantified using HRs, C statistics, and reclassification indices.</p>
Results: A total of 416 085 individuals (mean [SD] age, 56.6 [8.0] years; 224 642 female [54.0%]) with 30 797 AF cases were included. The PRS (HR per 1 SD, 1.65; 95% CI, 1.63-1.67; P < 1 × 10-8), AFgeneset (HR, 1.63; 95% CI, 1.52-1.75; P = 1.46 × 10-42), and CHIP (HR, 1.26; 95% CI, 1.15-1.38; P = 1.41 × 10-6) were associated with incident AF. The 5-year cumulative incidence of AF was at least 2-fold among individuals having all 3 genetic drivers (common, rare, and somatic drivers) compared with those with only 1 driver. Integration of IGM-AF with a clinical risk model (CHARGE-AF) showed higher predictive performance (C statistic, 0.80; 95% CI, 0.80-0.80) compared with IGM-AF and CHARGE-AF alone. The classification of the at-risk population for AF was improved when IGM-AF was added to CHARGE-AF (net reclassification index, 0.08; 95% CI, 0.07-0.09).</p>
Conclusions and Relevance: Results of this cohort study demonstrated the complementary value of common, rare, and somatic variants in shaping genomic AF risk. Leveraging comprehensive genetic information may enhance screening and preventive interventions for AF.</p>
14 Keywords
- Adult
- Aged
- Atrial Fibrillation
- Cohort Studies
- Female
- Genetic Predisposition to Disease
- Genetic Variation
- Humans
- Incidence
- Male
- Middle Aged
- Risk Assessment
- Risk Factors
- United Kingdom
22 Authors
- Rufan Zhang
- Min Seo Kim
- Wanqing Yin
- Shuangqiao Liao
- Xinyu Zhu
- Xiong Yang
- Kang Yu
- Yang Sui
- Carolina Roselli
- Shaan Khurshid
- Qiuli Chen
- Yunga A
- Hongqiang Zhao
- Tingfeng Xu
- Xiufeng Huang
- Jun Pu
- Zhaoqi Liu
- Pradeep Natarajan
- Guangyao Zhai
- Patrick T Ellinor
- Minxian Wang
- Akl C Fahed
1 Application
| Application ID | Title |
|---|---|
| 89885 | Genetics of complex diseases, comorbidities, and the disease risk prediction |
Enabling scientific discoveries that improve human health